We combine industry-specific expertise and services to produce the real-world evidence you need to meet your scientific and commercial objectives.
Late-phase studies and registries require unique capabilities from an EDC system. OmniComm TrialMaster has the flexibility and scalability to support all types of late-phase studies, from disease registries to long-term observational studies or any type of post marketing comparator studies. A growing list of drug and disease registries, some with more than 600 sites and 40,000 patients make OmniComm TrialMaster the right choice for late phase. OmniComm’s SaaS and license pricing models are sensitive to the budgets of late-phase trials and we offer competitive monthly fees on long trials and scalable pricing on large enrolling registries.
OmniComm TrialMaster meets the needs for late-phase, post-approval studies by:
Prior to the start of your next late-phase study, compare your checklist with ours and let us show you why TrialMaster has been chosen by many organizations as their late-phase electronic data capture of choice:
Our late-phase solution is uniquely positioned to address these key areas: